999TiPOVARIO: A single-arm, open-label phase II study of maintenance therapy with niraparib + bevacizumab (bev) in patients (pts) with advanced ovarian cancer (OC) after response to frontline platinum-based chemotherapy (chemo). (23rd October 2018) - Hardesty, M; Hope, J M; Krivak, T; Chen, J; Wainszelbaum, M; Gupta, D; Richardson, D